683 Capital Management »

Aziyo Biologics shares owned by 683 Capital Management

Quarter-by-quarter ownership of Aziyo Biologics (ELUT) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Aziyo Biologics

Tip: Access up to 7 years of quarterly data

All positions including Aziyo Biologics held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aziyo Biologics by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $302k 81k 3.74

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Madrigal Pharmaceuticals Put Option (MDGL)
Uniqure Nv SHS (QURE)
Alnylam Pharmaceuticals Put Option (ALNY)
Carvana Cl A (CVNA)
Insmed Com Par $.01 Put Option (INSM)
Uwm Holdings Corporation Com Cl A (UWMC)
Strategy Cl A New Put Option (MSTR)
Gxo Logistics Incorporated Common Stock (GXO)
Western Digital (WDC)
Novo-nordisk A S Adr Put Option (NVO)
United Therapeutics Corporation Put Option (UTHR)

View all positions for 683 Capital Management

Top funds holding Aziyo Biologics

Nantahala Capital Management
AIGH Capital Management
Silverarc Capital Management
Alyeska Investment Group
Deerfield Management Company
Vanguard Group
Perkins Capital Management
Knollwood Investment Advisory
Birchview Capital
Geode Capital Management
BlackRock
Jane Street
Renaissance Technologies
Citadel Advisors
Millennium Management

View all funds holding Aziyo Biologics